Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cysteine-rich intestinal protein
(
CRIP
), a double zinc-finger LIM protein, is expressed in great abundance in the intestine. We have found comparable levels of
CRIP
mRNA in peritoneal macrophages, peripheral blood mononuclear cells (PBMC), and lesser amounts in thymus and spleen. Because
CRIP
expression was high in immune cells, rats were challenged with
lipopolysaccharide
(
LPS
) to determine whether expression was altered during the acute-phase immune response. Immunocytochemistry showed that, in adherent mononuclear cells,
CRIP
protein was localized in the cytoplasm.
CRIP
mRNA levels increased over time after
LPS
injection in peritoneal macrophages, PBMC, spleen, and intestine. No changes in
CRIP
mRNA level were seen in either liver or thymus. In PBMC, the level of
CRIP
mRNA decreased before increasing later in the acute-phase immune response.
CRIP
protein was found in the plasma. Shortly after
LPS
administration plasma
CRIP
decreased, suggesting that
CRIP
was either passively diffused out of capillaries or was actively shunted into tissues to execute its function. Increased
CRIP
expression seen in response to
LPS
suggests that
CRIP
may play a role in immune cell activation or differentiation or in processes associated with cellular repair.
...
PMID:Lipopolysaccharide regulates cysteine-rich intestinal protein, a zinc-finger protein, in immune cells and plasma. 860 89
Cysteine-rich intestinal protein
(
CRIP
), a member of the LIM protein family, has a unique double zinc finger motif as the defining feature.
CRIP
is highly expressed in intestine and immune cells.
CRIP
transgenic (Tg) mice and nontransgenic controls were challenged with
lipopolysaccharide
(
LPS
). Serum concentrations of interferon-gamma and tumor necrosis factor-alpha were less while those of interleukin-6 and -10 were greater in the Tg mice following
LPS
administration.
CRIP
-overexpressing splenocytes produce the same cytokine profile. These responses are consistent with a regulatory role for this protein in cell differentiation, which produces an imbalance in Th1 and Th2 cytokines. Stimulation of
CRIP
protein levels by
LPS
is eliminated in metallothionein knockout mice, suggesting metallothionein is the source of zinc for this zinc finger protein and, further, that this could reflect a relationship to the zinc nutritional status and to the aberrant Th1/Th2 cytokine balance observed in zinc deficiency.
...
PMID:Regulation of cysteine-rich intestinal protein, a zinc finger protein, by mediators of the immune response. 1094 88
Cysteine-rich intestinal protein
(
CRIP
), which contains a double zinc finger motif, is a member of the Group 2 LIM protein family. Our results showed that the developmental regulation of
CRIP
in neonates was not influenced by conventional vs. specific pathogen-free housing conditions. Thymic and splenic
CRIP
expression was not developmentally regulated. A line of transgenic (Tg) mice that overexpress the rat
CRIP
gene was created. When challenged with
lipopolysaccharide
, the Tg mice lost more weight, exhibited increased mortality, experienced greater diarrhea incidence, and had less serum interferon-gamma (IFN-gamma) and more interleukin (IL)-6 and IL-10. Similarly, splenocytes from the Tg mice produced less IFN-gamma and IL-2 and more IL-10 and IL-6 upon mitogen stimulation. Delayed-type hypersensitivity response was less in the Tg mice. Influenza virus infection produced greater weight loss in the Tg mice, which also showed delayed viral clearance. The observed responses to overexpression of the
CRIP
gene are consistent with a role for this LIM protein in a cellular pathway that produces an imbalance in cytokine pattern favoring Th2 cytokines.
...
PMID:Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response. 1200 48